Beaverton, Ore. – June 2, 2015 – Radiant Pain Relief Centres, which administers an FDA cleared, non-surgical, non-narcotic treatment for chronic and neuropathic pain called scrambler therapy, has opened the second of 100 planned treatment centers in the U.S. this month in Beaverton, Ore. at 1600 SW Cedar Hills Blvd, south of Hwy. 26, and nearby the medical cluster anchored by Providence St. Vincent Medical Center. The location will operate under the care of Dr. David Farley, medical director of Radiant Pain Relief Centres as a satellite to its first clinic in West Linn. The team has treated more than 150 patients in its first year ending in February, resulting in an average reduction in pain by 81 percent for 30 to 90 days.
Chronic pain is defined as pain present for three months or longer that has developed some neuropathic or nerve-related pain. It is an epidemic that costs an estimated $600B in care and loss of productivity in the U.S. annually. It could include arthritis, chemo-induced peripheral neuropathy, herniated discs, neuropathic pain, sciatica, and more.
“We are excited about bringing the technology and clinical staff to Beaverton, which will allow us to deliver this transformative option for treating chronic pain more conveniently to patients living on the west side of town,” said P. Brendon Lundberg, CEO. “We believe that we can serve a significant portion of Washington and west Multnomah Counties from the Cedar Hills location, and are excited about expanding Radiant’s presence in the Portland metropolitan area.”
The company has plans to grow to more than 100 Radiant Pain Relief Centres over the next five years as a response to medical need in the U.S.
“We have treated patients with chronic pain resulting from injuries, diabetes, cancer, fibromyalgia, complex regional pain syndrome (CRPS), and other diseases. The resulting reduction of pain that Radiant’s therapy produces on all these conditions make it my priority to provide accessibility to as many patients as possible, as soon as possible,” said Dr. Farley. “We have established the most effective treatment protocols in the world for scrambler therapy, and will continue to refine this life-changing treatment alongside our research partners.”
Methodology of Scrambler Therapy
The technology was developed in Italy by Professor Giuseppe Marineo at the Medical Bioengineering Research Center in Rome, and was cleared by the FDA in 2009 under the term “scrambler therapy.” It uses a new theory of pain management that addresses the way the brain receives and interprets chronic pain information, rather that trying to suppress or dull the pain message. By using artificial intelligence that mimics the body’s natural healthy pain signaling, the technology replaces the chronic pain message with a no pain message to the brain, which, through neuroplasticity, learns and adopts this new messaging. The result is significant or total pain relief for nearly all types chronic pain, lasting an average of 30-90 days.
About Chronic Pain and Treatment
More than 100 million people in the U.S. suffer from chronic pain, according to American Academy of Pain Medicine, or nearly one in three people. Historical treatment approaches for chronic pain are limited, and often risky, costly or come with significant side effects. In fact, the most recent data from the National Survey on Drug Use and Health (NSDUH), in September 2014, ranked Oregon number one in the U.S. for the non-medical use of opioids—an illegal and often risky and potentially lethal use of painkiller medications. The high rate of opioid use in Oregon is part of a nationwide trend over the last two decades. Radiant Pain Relief Centres are uniquely positioned to address the epidemic of chronic pain; without drugs, needles, or surgery.
Patient Data
To date, Radiant Pain Relief Centres have gathered the following patient data:
• Average Reduction in pain as a score, 6.2
• Average Reduction in pain as a percentage, 81%
• Percentage reduced to zero or one, 50%
• Average reduction in pain area (rule of 9s), 66%
• Average number of initial treatments, 10 sessions
• Average duration of relief, 30-90 days
• Average number of maintenance boosters, avg. 5 treatment per 6 patients
• Percentage of patient who pursue therapy, 84%
• Patient demographics, approx. 50% male and female
About Radiant Pain Relief Centres
Radiant Pain Relief Centres are progressive, patient-centric care facilities that are effectively resolving the epidemic of chronic pain, a $600B healthcare and productivity cost in the U.S. Built around an exclusive FDA-cleared technology, scrambler therapy, Radiant Pain Relief Centres are able to create significant or total pain relief in most cases for 30-90 days following therapy without drugs, needles, surgery or side effects. This technology uses the information theory to retrain the brain through neuroplasticity and return the body to a more normal state of nervous system health, achieving significant, lasting pain relief. Delivered in a highly-refined care model, this technology makes the Radiant Pain Relief Centre approach the most effective and appealing way to treat chronic pain. For more information visit www.radiantpainrelief.com
